血管外肺水指数对严重脓毒症患者的预后评价.pdfVIP

  • 2
  • 0
  • 约1.96万字
  • 约 4页
  • 2017-05-30 发布于北京
  • 举报

血管外肺水指数对严重脓毒症患者的预后评价.pdf

血管外肺水指数对严重脓毒症患者的预后评价.pdf

796 • 广西医科大学学报 20140ct;3 1(5) epidermal growth factor receptor 2-positive metastatic ceptor 2-negative metastatic breast cancer [J J. J Clin breast cancer that progressed during prior trastuzumab Oncol. 2010. 28( 7) : 1 131-1 137. therapy [JJ. J Clin Oncol. 2010.28(7) ,1 138-1144. [19J Schneeweiss A. Chia S. Hickish T. et a l. Pertuzumab [17J Portera CC. Walshe JM. Rosing DR. et a l. Cardiac plus trastuzumab in combination with standard neoadju- toxicity and efficacy of trastuzumab

文档评论(0)

1亿VIP精品文档

相关文档